Thrice-weekly maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (AIDS) Josep Mallolas, Josep M. Gatell,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cavallo Clinical Microbiology and Infection

Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hydatid disease Clinical Microbiology and Infection

Thrice-weekly maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (AIDS) Josep Mallolas, Josep M. Gatell,

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Determination of cytomegalovirus DNA load for monitoring of cytomegalovirus disease and antiviral treatment in solid organ transplant patients, comparing.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Cutaneous sporotrichosis: the old iodide treatment remains effective

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

F.R. Gómez, E.P. de la Llave, J.M. García-Lechuz Moya

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Cephalosporins: a pharmacological update

Retrospective study of CMV retinitis in patients with AIDS

Epidemiology of opportunistic infections in AIDS patients

T. Lazzarotto, B. Guerra, L. Gabrielli, M. Lanari, M.P. Landini

Laboratory diagnosis and biosafety issues of biological warfare agents

Sepsis and neutropenia induced by clozapine

Uncommon opportunistic fungi: new nosocomial threats

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease Inge O. Baas, G. Johan A. Offerhaus, Ralph.

R. Colebunders, P. Michielsen Clinical Microbiology and Infection

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Training in infectious diseases and tropical medicine in Britain

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Statin use and clinical outcomes among pneumonia patients

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.

Overview of cefixime use in community-acquired infections

Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis C. Piketty, C. Bardin, J.

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells D. Lilleri,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Carratalà J. Clinical Microbiology and Infection

Community-acquired acute bacterial meningitis in the elderly in Turkey

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies J.C. Martín, V Soriano,

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Localized Mycobacterium avium complex infection in a patient on HAART

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

Thrice-weekly maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (AIDS) Josep Mallolas, Josep M. Gatell, Juan Luis Gómez-Sirvent, Elisabeth Buira, Laura Zamora, Jerusa Alecrim-Andrade, Alfredo Adán, Marta Morales, Josep M. Miró, Montserrat Loncá, Ana Guelar, Eladio Soriano Clinical Microbiology and Infection Volume 1, Issue 3, Pages 213-214 (March 1996) DOI: 10.1111/j.1469-0691.1996.tb00560.x Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Survival and control of CMV retinitis in 33 study patients receiving thrice-weekly maintenance ganciclovir or foscarnet therapy: (A) Time without retinitis progression (17 patients progressed, 16 censored: median 18 weeks): (B) Time of survival free of retinitis (25 patients died or relapsed, 8 censored; median 14 weeks); (C) Time of survival from diagnosis of retinitis (22 patients died, 11 censored; median 34 weeks). Clinical Microbiology and Infection 1996 1, 213-214DOI: (10.1111/j.1469-0691.1996.tb00560.x) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions